Vaxxinity has developed a novel platform that triggers a safe and specific antibody response against self-antigen, enabling the use of vaccines to treat chronic diseases. This webinar features advanced bioanalytical solutions for vaccine discovery and development from Sartorius, as well as a deep dive into Vaxxinity’s preclinical path to selecting vaccines, including a novel vaccine for Parkinson’s disease. Watch the On-Demand Webinar.
More efficient development of drugs with attractive side effect profiles requires robust, easy-to-use, cost-effective in vitro gut models that are physiologically representative of the human intestinal tract.
White Paper |
By Kimberly B. Shepard, Amanda M. Pluntze, and David T. Vodak,Lonza
Three combination case studies are demonstrated, in which bevacizumab is paired with erlotinib, cisplatin, or paclitaxel in a dry powder inhaler formulation.
Cost efficiencies and expertise again go hand in hand, with companies often outsourcing or partnering primarily to gain access to manufacturing know-how.
Critical quality attributes are fundamental to regulatory compliance in drug development and manufacturing. Learn how surface plasmon resonance has been applied for protein characterization of antibody effector function.
The pros and cons of soluble and insoluble processes: isolating, solubilizing, and properly refolding, and strategies to improve the performance of IB processes.
As we look forward to the future of drug development, a panel comprising industry consultants and early development experts discussed examining new short- and long-term CDMO and supply chain strategies.
